NASDAQ:ASND - Ascendis Pharma A/S Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$122.37 -0.52 (-0.42 %)
(As of 05/19/2019 04:00 PM ET)
Previous Close$122.37
Today's Range$121.0375 - $123.27
52-Week Range$53.21 - $131.76
Volume188,399 shs
Average Volume281,405 shs
Market Capitalization$5.16 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Ascendis Pharma A/S (NASDAQ:ASND) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
9 Wall Street analysts have issued ratings and price targets for Ascendis Pharma A/S in the last 12 months. Their average twelve-month price target is $135.00, suggesting that the stock has a possible upside of 10.32%. The high price target for ASND is $219.00 and the low price target for ASND is $81.00. There are currently 9 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $135.00$135.00$86.25$77.50
Price Target Upside: 10.32% upside17.71% upside17.00% upside21.29% upside

Ascendis Pharma A/S (NASDAQ:ASND) Consensus Price Target History

Price Target History for Ascendis Pharma A/S (NASDAQ:ASND)

Ascendis Pharma A/S (NASDAQ:ASND) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/8/2019WedbushReiterated RatingBuy$219.00HighView Rating Details
4/5/2019Canaccord GenuityBoost Price TargetBuy ➝ Buy$132.00 ➝ $133.00LowView Rating Details
3/29/2019Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$151.00 ➝ $139.00LowView Rating Details
3/25/2019Evercore ISIInitiated CoverageOutperform ➝ OutperformHighView Rating Details
3/18/2019Cantor FitzgeraldReiterated RatingBuy$185.00LowView Rating Details
3/7/2019JPMorgan Chase & Co.Boost Price TargetOverweight$85.00 ➝ $145.00MediumView Rating Details
1/24/2019Leerink SwannUpgradeMarket Perform ➝ Outperform$73.00 ➝ $90.00LowView Rating Details
8/30/2018Wells Fargo & CoBoost Price TargetOutperform$83.00 ➝ $88.00HighView Rating Details
8/30/2018Stifel NicolausLower Price TargetBuy ➝ Buy$85.00 ➝ $81.00HighView Rating Details
1/25/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$45.00 ➝ $60.00HighView Rating Details
1/19/2018HC WainwrightReiterated RatingBuyMediumView Rating Details
(Data available from 5/19/2017 forward)
This page was last updated on 5/19/2019 by Staff

Featured Article: What is insider trading?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel